Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

84.88
+0.27000.32%
Volume:66.59K
Turnover:5.65M
Market Cap:3.54B
PE:- -
High:85.08
Open:84.82
Low:84.58
Close:84.61
52wk High:85.46
52wk Low:64.30
Shares:41.75M
Float Shares:41.75M
Volume Ratio:1.72
T/O Rate:0.16%
Dividend:1.02
Dividend Rate:1.21%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
19 mins ago

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
25 mins ago

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
1 hour ago

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
1 hour ago

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
1 hour ago

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
1 hour ago

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
1 hour ago

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
2 hours ago

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
2 hours ago

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
2 hours ago

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
3 hours ago

Merck price target raised to $180 from $155 at Wolfe Research

TIPRANKS
·
4 hours ago

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
7 hours ago

Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes

TIPRANKS
·
9 hours ago

Molecular Partners H1 Net Loss Narrows on Lower R&D Expenses

Reuters
·
9 hours ago

SEC Joins National Project for Next-Generation Radiotherapy System

TIPRANKS
·
12 hours ago

BetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program

TIPRANKS
·
14 hours ago

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.
·
15 hours ago

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
16 hours ago

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
16 hours ago